Fund profile · Compiled from public sources

Droia Ventures

Pre-seed → Series A

Their stated focus (public profile)

Droia Ventures invests globally in early-stage drug development companies focused exclusively on therapeutics for oncology and genetic disease. The fund targets novel science and innovative approaches that address previously unsolvable clinical problems with the potential for clinical breakthrough. Droia takes a hands-on approach, supporting portfolio companies from company creation through clinical proof of concept, with an in-house team of drug development and biotech experts who may take interim roles within companies.

Stages: Pre-seed → Series A

Sectors: Life sciences

On file: 20 companies on record

Website: droiaventures.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →